From the point of view of experts, the limited access to cardiac treatments in the pandemic year 2020 is likely to continue to have an impact in the future.
"Overall, the supply of surgeries and interventions has been significantly restricted," said the CEO of the German Heart Foundation, Thomas Voigtländer, on Wednesday in Berlin at the presentation of the 2021 heart report, in which several specialist societies were involved. Consequences can certainly be expected in the years to come. Exactly how this will look like is still speculative - delayed use of pacemakers, for example, gave rise to fears of a worse development.
The goal is early prevention
In 2020, around 338,000 deaths from cardiovascular diseases were recorded in Germany - it is by far the most common cause of death, said Voigtländer. A high proportion of cardiovascular diseases can also be assumed among the patients who died of or with Covid-19. Such diseases are considered a risk factor for severe courses of a corona infection.
Because of the aging society, increasing patient numbers are to be expected in the future, it said. Heart failure, for example, will therefore remain a challenge, and the aim must be early prevention. The development of mortality from heart attacks was highlighted as a positive development: while in 2000 around 105 people per 100,000 inhabitants died from it, in 2020 it was only around 48.